Personal Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $33.5M | Sell |
448,566
-87,667
| -16% | -$6.54M | 0.16% | 117 |
|
|
2022
Q3 | $44.3M | Buy |
+536,233
| New | +$44.3M | 0.24% | 99 |
|
|
2022
Q1 | – | Sell |
-522,291
| Closed | -$67.8M | – | 510 |
|
|
2021
Q4 | $67.8M | Buy |
522,291
+10,742
| +2% | +$1.39M | 0.31% | 77 |
|
|
2021
Q3 | $57.9M | Buy |
511,549
+16,255
| +3% | +$1.84M | 0.29% | 81 |
|
|
2021
Q2 | $51.3M | Buy |
495,294
+51,240
| +12% | +$5.31M | 0.27% | 94 |
|
|
2021
Q1 | $37.1M | Buy |
444,054
+104,125
| +31% | +$8.71M | 0.22% | 109 |
|
|
2020
Q4 | $31M | Buy |
339,929
+98,333
| +41% | +$8.97M | 0.2% | 109 |
|
|
2020
Q3 | $19.3M | Buy |
241,596
+198,188
| +457% | +$15.8M | 0.15% | 112 |
|
|
2020
Q2 | $3M | Buy |
43,408
+38,059
| +712% | +$2.63M | 0.02% | 195 |
|
|
2020
Q1 | $329K | Sell |
5,349
-1,179
| -18% | -$72.5K | ﹤0.01% | 278 |
|
|
2019
Q4 | $508K | Buy |
6,528
+1,068
| +20% | +$83.1K | ﹤0.01% | 260 |
|
|
2019
Q3 | $400K | Buy |
5,460
+1,191
| +28% | +$87.3K | ﹤0.01% | 267 |
|
|
2019
Q2 | $263K | Buy |
4,269
+183
| +4% | +$11.3K | ﹤0.01% | 285 |
|
|
2019
Q1 | $261K | Buy |
+4,086
| New | +$261K | ﹤0.01% | 285 |
|